RT Journal Article
SR Electronic
T1 719 Phase 1 clinical trial design of ZM008, a first-in-class anti LLT1 antibody is a promising therapy for multiple solid cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A814
OP A814
DO 10.1136/jitc-2023-SITC2023.0719
VO 11
IS Suppl 1
A1 Ghosh, Maloy
A1 Tiwari, Anurag
A1 Dubey, Ashvini Kumar
A1 Bhattacharjee, Sanghamitra
A1 Manjunath, Yogendra
A1 Kashipathi, Shalini
A1 Krishna, Subith
A1 Mandal, Tirtha
A1 Gnanasegaran, Soorya
A1 Garcia-Ribas, Ignacio
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A814.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.